1. Home
  2. TKC vs LEGN Comparison

TKC vs LEGN Comparison

Compare TKC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turkcell Iletisim Hizmetleri AS

TKC

Turkcell Iletisim Hizmetleri AS

N/A

Current Price

$4.82

Market Cap

4.4B

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$17.42

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TKC
LEGN
Founded
1993
2014
Country
Turkey
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.6B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
TKC
LEGN
Price
$4.82
$17.42
Analyst Decision
Buy
Buy
Analyst Count
2
13
Target Price
$7.38
★ $42.46
AVG Volume (30 Days)
2.3M
★ 2.3M
Earning Date
11-09-2026
11-10-2026
Dividend Yield
★ 3.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.23
$38.71
Revenue Next Year
$27.60
$18.83
P/E Ratio
$26.98
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.46
$16.24
52 Week High
$7.18
$37.50

Technical Indicators

Market Signals
Indicator
TKC
LEGN
Relative Strength Index (RSI) 50.16 37.79
Support Level $4.49 $17.43
Resistance Level $5.22 $19.92
Average True Range (ATR) 0.09 1.50
MACD 0.04 -0.47
Stochastic Oscillator 68.60 1.15

Price Performance

Historical Comparison
TKC
LEGN

About TKC Turkcell Iletisim Hizmetleri AS

Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: